All Essential Facts
Investor Information
Optimi Health is committed to developing high-quality, GMP-compliant MDMA and psilocybin products to support emerging mental health treatments. With a focus on regulatory compliance and real-world data collection, we are steadily expanding our presence in global markets. Our careful approach to growth ensures sustainable progress while prioritizing patient safety and product excellence, offering investors a solid foundation in the evolving psychedelic sector.
All Essential Facts
Investor Information
Optimi Health is committed to developing high-quality, GMP-compliant MDMA and psilocybin products to support emerging mental health treatments. With a focus on regulatory compliance and real-world data collection, we are steadily expanding our presence in global markets. Our careful approach to growth ensures sustainable progress while prioritizing patient safety and product excellence, offering investors a solid foundation in the evolving psychedelic sector.
All Essential Facts
Investor Information
Optimi Health is committed to developing high-quality, GMP-compliant MDMA and psilocybin products to support emerging mental health treatments. With a focus on regulatory compliance and real-world data collection, we are steadily expanding our presence in global markets. Our careful approach to growth ensures sustainable progress while prioritizing patient safety and product excellence, offering investors a solid foundation in the evolving psychedelic sector.
Vision
Vision
To be a global industry leader in psychedelics, setting the standard for safe, accessible, and effective therapeutic solutions that transform mental health treatment worldwide.
To be a global industry leader in psychedelics, setting the standard for safe, accessible, and effective therapeutic solutions that transform mental health treatment worldwide.
Mission
Mission
To produce high-quality, GMP-compliant psychedelic therapies that advance global mental health, driven by innovation, rigorous standards, and patient-focused outcomes.
To produce high-quality, GMP-compliant psychedelic therapies that advance global mental health, driven by innovation, rigorous standards, and patient-focused outcomes.
Investor Highlights
Optimi Health is a Health Canada-approved GMP manufacturer specializing in MDMA and psilocybin for therapeutic use.
With prescribable products already available in regulated markets like Australia, we have a proven ability to meet stringent quality and compliance standards.
Our advanced production facilities and Drug Establishment Licence enable us to produce cost-effective solutions at scale, positioning us ahead in the evolving psychedelic industry. By leveraging real-world data and patient outcomes, Optimi Health is building a strong foundation for long-term growth and expansion into new global markets.
Two Drugs In-Market for Patient Use
Optimi has MDMA and Psilocybin capsules available to treat PTSD and TRD in Australia. Compass, Atai, Lykos and others in the industry cannot make this claim.
Two Drugs In-Market for Patient Use
Optimi has MDMA and Psilocybin capsules available to treat PTSD and TRD in Australia. Compass, Atai, Lykos and others in the industry cannot make this claim.
Two Drugs In-Market for Patient Use
Optimi has MDMA and Psilocybin capsules available to treat PTSD and TRD in Australia. Compass, Atai, Lykos and others in the industry cannot make this claim.
Years Ahead of the Competition
The competition is still in the clinical development phase, giving Optimi a significant head start on establishing sales channels and market share.
Years Ahead of the Competition
The competition is still in the clinical development phase, giving Optimi a significant head start on establishing sales channels and market share.
Years Ahead of the Competition
The competition is still in the clinical development phase, giving Optimi a significant head start on establishing sales channels and market share.
De-Risked by Comparison
While others spend hundreds of millions of dollars with no guarantees of approval, Optimi is in-market today collecting Real World Evidence and evaluating Australian Patient Outcome data for NDA submissions globally.
De-Risked by Comparison
While others spend hundreds of millions of dollars with no guarantees of approval, Optimi is in-market today collecting Real World Evidence and evaluating Australian Patient Outcome data for NDA submissions globally.
De-Risked by Comparison
While others spend hundreds of millions of dollars with no guarantees of approval, Optimi is in-market today collecting Real World Evidence and evaluating Australian Patient Outcome data for NDA submissions globally.
Future Rescheduled Market Opportunities
As countries look to follow Australia, Optimi is ready to export via their Drug Establishment Licence allowing access to patients in regulated markets.
Future Rescheduled Market Opportunities
As countries look to follow Australia, Optimi is ready to export via their Drug Establishment Licence allowing access to patients in regulated markets.
Future Rescheduled Market Opportunities
As countries look to follow Australia, Optimi is ready to export via their Drug Establishment Licence allowing access to patients in regulated markets.
Stay Updated With Our Recent SEDAR Filings
Explore our latest SEDAR filings and gain insights into the company’s regulatory disclosures and financial updates.
Optimi Health's Stock Performance
Optimi Health's Stock Performance
Track Optimi Health’s stock performance as we advance in the psychedelic industry. With high-quality GMP-compliant therapies and a focus on sustainable growth, we’re delivering value to stakeholders and driving innovation in mental health treatment.
Track Optimi Health’s stock performance as we advance in the psychedelic industry. With high-quality GMP-compliant therapies and a focus on sustainable growth, we’re delivering value to stakeholders and driving innovation in mental health treatment.
CSE: OPTI
OTC: OPTHF
FWB: 8BN
CSE: OPTI
OTC: OPTHF
FWB: 8BN
Subscribe to our Newsletter
Stay updated with the latest information and news.
Subscribe to our Newsletter
Stay updated with the latest information and news.
Subscribe to our Newsletter
Stay updated with the latest information and news.
Optimi Health is a Health Canada-licensed GMP pharmaceutical manufacturer specializing in MDMA and psilocybin. Committed to advancing mental health treatments, we deliver high-quality, cost-effective solutions for global markets.
Reach Us
Optimi Health is a Health Canada-licensed GMP pharmaceutical manufacturer specializing in MDMA and psilocybin. Committed to advancing mental health treatments, we deliver high-quality, cost-effective solutions for global markets.
Reach Us
Optimi Health is a Health Canada-licensed GMP pharmaceutical manufacturer specializing in MDMA and psilocybin. Committed to advancing mental health treatments, we deliver high-quality, cost-effective solutions for global markets.